V Wealth Advisors’s AstraZeneca AZN Stock Holding History

V Wealth Advisors’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-3,020	Closed	-$432K	–	137
2023 Q2	$432K	Hold	3,020	–	–	0.07%	222
2023 Q1	$419K	Sell	3,020 -24	-0.8%	-$3.23K	0.08%	225
2022 Q4	$413K	Buy	+3,044	New	+$382K	0.09%	219
2022 Q3	–	Sell	-1,655	Closed	-$219K	–	378
2022 Q2	$219K	Hold	1,655	–	–	0.04%	370
2022 Q1	$220K	Buy	+1,655	New	+$198K	0.04%	404
2017 Q3	–	Sell	-99	Closed	-$7K	–	235
2017 Q2	$7K	Buy	+99	New	+$6.46K	﹤0.01%	613

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $53.8B AUM 19.23% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

V Wealth Advisors's AZN Position: Q3 2023 in Review

V Wealth Advisors sold out of AstraZeneca (AZN) in Q3 2023, closing a stake of 3,020 shares — an estimated $432K sold.

V Wealth Advisors first reported a position in AZN in Q2 2017 and held it in 6 quarters. The position peaked at $432K in Q2 2023. 1,073 funds tracked by Wall St. Rank hold AZN as of Q3 2023.

V Wealth Advisors reported no remaining AstraZeneca position as of Q3 2023 after selling out during the quarter.
V Wealth Advisors sold 3,020 AstraZeneca shares in Q3 2023, an estimated $432K.
V Wealth Advisors first reported a position in AstraZeneca in Q2 2017 and held it in 6 quarters.
V Wealth Advisors's AstraZeneca position peaked at $432K in Q2 2023.
1,073 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2023.

Based on V Wealth Advisors's 13F filing for Q3 2023, filed 15 Nov 2023.